Speaker illustration

Doctor Kirstin Stricker

Novartis Pharma, Basel (Switzerland)

Large number of real world evidence studies confirmed effectiveness and safety in treatment with Val/Aml and Val/Aml/HCT worldwide across various ethical groups, disease severities and co-morbidities

Event: ESC CONGRESS 2017

Topic: Treatment of hypertension

Session: Hypertension drug treatment

Thumbnail

ESC 365 is supported by

logo Novo Nordisk